Arbutus Biopharma Corp ( ABUS) - Stock Earnings
ABUS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.8 million USD | 1.1 million USD |
| 2026Q1 | 169.7 million USD | 179.1 million USD |
| 2026Q2 | -5.1 million USD | 1.0 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ABUS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -72.8 million USD | 18.1 million USD |
| 2024 | -69.9 million USD | 6.2 million USD |
| 2025 | -33.5 million USD | 14.1 million USD |
| 2026 Est. | — | — |
ABUS
Price: $4.86
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.79 USD
P/E Ratio: 5.91
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 545700
Ebitda: -10.9 millionMarket Capitalization: 1.0 billion